Riskpilot← Back to searchSign inGet full accessOlo-apteekki Oy
OYActiveY-tunnus 2862688-1Muuntotie 1-A1Retail sale of medical and orthopaedic goods · NACE 4774Est. 201712 employeeswww.oloapteekki.fi
Revenue 2025
EUR 15,2M
+48% vs 2024
EBITDA margin
1.8%
+43% vs 2024
Equity ratio
13.9%
Financial strength
Net profit 2025
EUR 85K
+625% vs 2024
| Revenue | EUR 15,2M | +48% |
| EBITDA | EUR 280K | +43% |
| Net profit | EUR 85K | +625% |
| Total assets | EUR 2,3M | +40% |
| Equity | EUR 313K | +38% |
| Employees | 12 | — |
Legal name
Olo-apteekki Oy
Y-tunnus number
2862688-1
Legal form
Osakeyhtiö
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
13. lokakuuta 2017
Share capital
EUR 2 500
Employees
12 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsen ja toimitusjohtaja yhdessä sekä hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on terveydenhoitotarvikkeiden vähittäiskauppa, apteekit ja laajan valikoiman postimyynti ja verkkokauppa. Yhtiön toimiala on kosmetiikan, lääkkeiden ja terveyspalveluiden vähittäismyynti sekä kosmetiikan, lääkkeiden ja terveyspalveluiden myyntiin liittyvien tukipalveluiden tarjoaminen. Kosmetiikan, lääkkeiden ja terveystuotteiden hankinta ja tukkukauppa sekä kaikki muu laillinen liiketoiminta.
Address
Muuntotie 1-A1
Website
www.oloapteekki.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 544 | 2 740 | 6 744 | 10 280 | 15 212 |
| Staff expenses | −647 | −545 | −554 | −481 | −993 |
| EBITDA | −1 067 | −794 | −140 | 196 | 280 |
| Depreciation & amort. | −119 | −173 | −214 | −227 | −178 |
| EBIT | −1 187 | −967 | −354 | −32 | 102 |
| Net financials | −8 | −0 | −2 | −1 | −25 |
| Profit before tax | −1 232 | −981 | −362 | 12 | 85 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −1 232 | −981 | −362 | 12 | 85 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 517 | 1 523 | 1 489 | 1 613 | 2 258 |
| Equity | 2 131 | 1 162 | 100 | 227 | 313 |
| Long-term debt | 21 | 23 | 0 | 0 | 0 |
| Short-term debt | 365 | 338 | 1 262 | 1 304 | 1 872 |
| Total debt | 386 | 361 | 1 262 | 1 304 | 1 872 |
EBITDA margin
1.8%
This company
15.8%
Market median
-89% vs market
20212025
Equity ratio
13.9%
This company
38.2%
Market median
-64% vs market
20212025
Return on equity
27.3%
This company
18.4%
Market median
+48% vs market
20212025
Net profit margin
0.6%
This company
8.1%
Market median
-93% vs market
20212025
Asset turnover
6.74×
This company
1.12×
Market median
+502% vs market
20212025
Debt / equity
6.22×
This company
0.62×
Market median
-903% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-02-01 – 2022-01-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-02-01 – 2021-01-31
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
NM Deputy Member | Deputy Member | 2022 |
AT Chief Executive Officer | Chief Executive Officer | 2019 |
MM | Audit | 2025 |
SR Deputy auditor | Deputy auditor | 2025 |
MJ Confidential Clerk | Confidential Clerk | 2021 |
| Former (3) | ||
| Audit | 2019 – 2023 | |
RM Confidential Clerk | Confidential Clerk | 2019 – 2021 |
KM Chief Executive Officer | Chief Executive Officer | 2017 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairperson | 2025 | |
| Former (11) | ||
| Board of Directors | 2019 – 2022 | |
| Board of Directors | 2019 – 2022 | |
| Board of Directors | 2019 – 2022 | |
| Board of Directors | 2019 – 2019 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2020 – 2021 | |
| Chairperson | 2021 – 2022 | |
| Board of Directors | 2019 – 2022 | |
| Board of Directors | 2017 – 2020 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2019 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 73.8% | 73.8% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tamro Oyj
Olo-apteekki Oy Board members of Olo-apteekki Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nina Maria Forssell | Deputy Member | 0 companies |
| Aleksi Tapani Routama | Chief Executive Officer | 0 companies |
| Minna Marianne Peräkorpi | Audit | 0 companies |
| Tuija Päivi Hannele Pursiainen | Audit | 0 companies |
| Riitta Maria Heiskanen | Confidential Clerk | 0 companies |
| Kai Mauri Kaasalainen | Chief Executive Officer | 0 companies |
| Stefan Rolf Axel Wiklund | Deputy auditor | 0 companies |
| Mari Johanna Savolainen | Confidential Clerk | 0 companies |
| Aki Tapio Koskinen | Board of Directors | 0 companies |
| Tiina Johanna Vaitomaa | Board of Directors | 0 companies |
| Eeva-Kaisa Mäki-Moijala | Board of Directors | 0 companies |
| Kati Marjatta Vuorikallas | Board of Directors | 0 companies |
| Juhana Rintala | Board of Directors | 0 companies |
| Anni Maria Svala | Board of Directors | 0 companies |
| Lars Kenneth Christian Forssell | Chairperson | 0 companies |
| Niklas Mikael Nylander | Chairperson | 0 companies |
| Eeva Silja Nyberg-Oksanen | Board of Directors | 0 companies |
| Petri Olavi Kansi | Board of Directors | 0 companies |
| Juho Valtteri Taube | Board of Directors | 0 companies |
| Pia Marika Westman | Board of Directors | 0 companies |